Quick Takeaways
- This page summarizes Andrew J. Murphy's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 11 Dec 2025, 16:32.
Andrew J. Murphy - 09 Dec 2025 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)
- Role
- EVP Research
- Signature
- /s/ Andrew Murphy
- Issuer symbol
- REGN
- Transactions as of
- 09 Dec 2025
- Net transactions value
- -$2,966,686
- Form type
- 4
- Filing time
- 11 Dec 2025, 16:32:45 UTC
- Previous filing
- 09 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Andrew J. Murphy filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 11 Dec 2025."
What Changed
- Previous filing in this sequence was filed on 09 Dec 2025.
- Current net transaction value: -$2,966,686.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MURPHY ANDREW J | EVP Research | 777 OLD SAW MILL RIVER ROAD, TARRYTOWN | /s/ Andrew Murphy | 11 Dec 2025 | 0001796226 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | REGN | Common Stock | Tax liability | $2,966,686 | -4,229 | -8.1% | $701.51 | 47,833 | 09 Dec 2025 | Direct | |
| holding | REGN | Common Stock | 4,375 | 09 Dec 2025 | By 401(k) Plan |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.